Testing effectiveness (Phase 2)Study completedNCT00147680What this trial is testingUterine Papillary Serous Cancer (UPSC) TrialWho this might be right forUterine Cancer Queensland Centre for Gynaecological Cancer 30
Testing effectiveness (Phase 2)UnknownNCT00003560What this trial is testingDocetaxel Plus Carboplatin in Treating Patients With Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal CancerWho this might be right forEndometrial CancerFallopian Tube CancerOvarian Cancer+1 more Herbert Irving Comprehensive Cancer Center 40
Large-scale testing (Phase 3)Active Not RecruitingNCT04095364What this trial is testingLetrozole With or Without Paclitaxel and Carboplatin in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Primary Peritoneal CancerWho this might be right forLow Grade Fallopian Tube Serous AdenocarcinomaOvarian Low Grade Serous AdenocarcinomaPrimary Peritoneal Low Grade Serous Adenocarcinoma+9 more NRG Oncology 450
Large-scale testing (Phase 3)Study completedNCT00005583What this trial is testingRadiation Therapy With or Without Chemotherapy in Treating Patients With High-Risk Endometrial CancerWho this might be right forEndometrial Cancer Nordic Society of Gynaecological Oncology - Clinical Trials Unit 400
Large-scale testing (Phase 3)Study completedNCT02101788What this trial is testingTrametinib in Treating Patients With Recurrent or Progressive Low-Grade Ovarian Cancer or Peritoneal Cavity CancerWho this might be right forBorderline Ovarian Serous TumorMicropapillary Serous CarcinomaOvarian Serous Adenocarcinoma+3 more National Cancer Institute (NCI) 260
Testing effectiveness (Phase 2)Study completedNCT00515073What this trial is testingPapillary Serous Carcinoma of the EndometriumWho this might be right forEndometrial Cancer M.D. Anderson Cancer Center 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT04575961What this trial is testingStudy of Pembrolizumab Combination With Chemotherapy in Platinum-sensitive Recurrent Low-grade Serous Ovarian CancerWho this might be right forOvarian CancerLow Grade Serous CarcinomaPrimary Peritoneal Carcinoma+1 more North Eastern German Society of Gynaecological Oncology 33
Early research (Phase 1)Looking for participantsNCT05238922What this trial is testingStudy of INCB123667 in Subjects With Advanced Solid TumorsWho this might be right forSolid Tumors Incyte Corporation 604
Testing effectiveness (Phase 2)Study completedNCT00231868What this trial is testingRadiation Therapy and Paclitaxel and Carboplatin in Patients With Uterine Papillary Serous CarcinomaWho this might be right forUterine Cancer Montefiore Medical Center 81
Testing effectiveness (Phase 2)Study completedNCT00416455What this trial is testingFludeoxyglucose (FDG) F 18 PET Scan, CT Scan, and Ferumoxtran-10 MRI Scan Before Chemotherapy and Radiation Therapy in Finding Lymph Node Metastasis in Patients With Locally Advanced Cervical Cancer or High-Risk Endometrial CancerWho this might be right forCervical AdenocarcinomaCervical Adenosquamous Cell CarcinomaCervical Small Cell Carcinoma+11 more National Cancer Institute (NCI) 384
Testing effectiveness (Phase 2)Study completedNCT00025467What this trial is testingThalidomide in Treating Patients With Recurrent or Persistent Endometrial CancerWho this might be right forEndometrial AdenoacanthomaEndometrial AdenocarcinomaEndometrial Adenosquamous Cell Carcinoma+3 more National Cancer Institute (NCI) 60
Testing effectiveness (Phase 2)Study completedNCT00551070What this trial is testingSelumetinib Sulfate in Treating Woman With Recurrent Low-Grade Ovarian Cancer or Peritoneum CancerWho this might be right forBorderline Ovarian Serous TumorLow Grade Ovarian Serous AdenocarcinomaMicropapillary Serous Carcinoma+3 more National Cancer Institute (NCI) 52
Not applicableStudy completedNCT01344837What this trial is testingBiomarkers in Blood and Tissue Samples From Patients With Uterine CancerWho this might be right forEndometrial Serous AdenocarcinomaStage I Uterine Corpus CancerStage II Uterine Corpus Cancer+2 more Gynecologic Oncology Group 360
Testing effectiveness (Phase 2)Ended earlyNCT00506779What this trial is testingGleevec/Taxol for Patients With Uterine Papillary Serous CarcinomaWho this might be right forUterine Cancer M.D. Anderson Cancer Center 17
Testing effectiveness (Phase 2)Study completedNCT00072176What this trial is testingTemsirolimus in Treating Patients With Metastatic or Locally Advanced Recurrent Endometrial CancerWho this might be right forEndometrial AdenocarcinomaEndometrial Adenosquamous Cell CarcinomaEndometrial Clear Cell Carcinoma+7 more National Cancer Institute (NCI) 62
Testing effectiveness (Phase 2)Study completedNCT00022620What this trial is testingPaclitaxel in Treating Patients With Refractory or Recurrent Endometrial CancerWho this might be right forEndometrial Cancer European Organisation for Research and Treatment of Cancer - EORTC
Large-scale testing (Phase 3)Study completedNCT00006027What this trial is testingComparison of Radiation Therapy With or Without Combination Chemotherapy Following Surgery in Treating Patients With Stage I or Stage II Endometrial CancerWho this might be right forEndometrial Cancer Radiation Therapy Oncology Group
Testing effectiveness (Phase 2)Ended earlyNCT00231829What this trial is testingA Pilot Study of Celecoxib in Patients With Grade 2 or 3 Uterine CancersWho this might be right forUterine Cancer Mark H. Einstein 23
Early research (Phase 1)Study completedNCT01198184What this trial is testingGamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 and Temsirolimus in Treating Patients With Advanced Solid TumorsWho this might be right forEndometrial Papillary Serous CarcinomaRecurrent Endometrial CarcinomaRecurrent Renal Cell Cancer+5 more National Cancer Institute (NCI) 18
Early research (Phase 1)WithdrawnNCT02050009What this trial is testingMetformin Hydrochloride, Carboplatin, and Paclitaxel in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal CancerWho this might be right forOvarian Papillary Serous CarcinomaOvarian Serous CystadenocarcinomaRecurrent Fallopian Tube Cancer+3 more Fox Chase Cancer Center